GM2-KLH vaccine
A cancer vaccine consisting of GM2 ganglioside, a melanoma-specific antigen, conjugated with the immunostimulant keyhole limpet hemocyanin. Vaccination with GM2-KLH vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against GM2 ganglioside-expressing melanoma cells, resulting in tumor growth inhibition.
| Synonym: | GM2-KLH ganglioside KLH-conjugated GM2 Ganglioside Vaccine |
|---|---|
| Abbreviation: | GM2-KLH |